Name | Value |
---|---|
Revenues | 132.8K |
Cost of Revenue | 65.8K |
Gross Profit | 67.0K |
Operating Expense | 1,785.0K |
Operating I/L | -1,718.0K |
Other Income/Expense | 261.0K |
Interest Income | 260.9K |
Pretax | -1,457.0K |
Income Tax Expense | -0.0K |
Net Income/Loss | -1,457.0K |
Sunshine Biopharma, Inc. is a pharmaceutical and nutritional supplement company specializing in the research and development of anticancer drugs. Their flagship product, Adva-27a, is designed to treat various forms of cancer and eliminate multidrug resistant cancer cells. Additionally, the company is developing SBFM-PL4, an anti-coronavirus treatment compound. Sunshine Biopharma also offers Essential 9, a nutritional supplement tablet, and Essential Calcium-Vitamin D supplement. They generate revenue through the sale of these science-based nutritional supplements and the potential future commercialization of their anticancer and anti-coronavirus drugs.